Publications of Matthias L. Schroeter

Schroeter, M. L.; Pawelke, S.; Bisenius, S.; Kynast, J.; Schuemberg, K.; Polyakova, M.; Anderl-Straub, S.; Danek, A.; Fassbender, K.; Jahn, H. et al.; Jessen, F.; Kornhuber, J.; Lauer, M.; Prudlo, J.; Schneider, A.; Uttner, I.; Thöne-Otto, A. I. T.; Otto, M.; Diehl-Schmid, J.; FTLD Study Group Germany: A modified reading the mind in the eyes test predicts behavioral variant frontotemporal dementia better than executive function tests. Frontiers in Aging Neuroscience 10, 11 (2018)

Polyakova, M.; Schlögl , H.; Sacher, J.; Schmidt-Kassow , M.; Kaiser, J.; Stumvoll, M.; Kratzsch, J.; Schroeter, M. L.: Stability of BDNF in human samples stored up to 6 months and correlations of serum and EDTA-plasma concentrations. International Journal of Molecular Sciences 18 (6), 1189 (2017)

Albrecht, F.; Bisenius, S.; Schaack, R. M.; Neumann, J.; Schroeter, M. L.: Disentangling the neural correlates of corticobasal syndrome and corticobasal degeneration with systematic and quantitative ALE meta-analyses. npj Parkinson's Disease 3, 12 (2017)

Schümberg, K.; Polyakova, M.; Steiner, J.; Schroeter, M. L.: Serum S100B is related to illness duration and clinical symptoms in schizophrenia: A meta-regression analysis. Frontiers in Cellular Neuroscience 10, 46 (2016)

Polyakova, M.; Schroeter, M. L.; Elzinga, B. M.; Holiga, Š.; Schoenknecht, P.; de Kloet, E. R.; Molendijk, M. L.: Brain-derived neurotrophic factor and antidepressive effect of electroconvulsive therapy: Systematic review and meta-analyses of the preclinical and clinical literature. PLoS One 10 (11), e0141564 (2015)

Polyakova, M.; Sander, C.; Arélin, K.; Lampe, L.; Luck, T.; Luppa, M.; Kratzsch, J.; Hoffmann, K.-T.; Riedel-Heller, S.; Villringer, A. et al.; Schoenknecht, P.; Schroeter, M. L.: First evidence for glial pathology in late life minor depression: S100B is increased in males with minor depression. Frontiers in Cellular Neuroscience 9, 406 (2015)

Holiga, Š.; Mueller, K.; Möller, H. E.; Urgosik, D.; Ruzicka, E.; Schroeter, M. L.; Jech, R.: Resting-state functional magnetic resonance imaging of the subthalamic microlesion and stimulation effects in Parkinson's disease: Indications of a principal role of the brainstem. NeuroImage: Clinical 9, pp. 264 - 274 (2015)

Schroeter, M. L.; Mueller, K.; Arélin, K.; Sacher, J.; Holiga, Š.; Kratzsch, J.; Luck, T.; Riedel-Heller, S.; Villringer, A.: Serum neuron-specific enolase is related to cerebellar connectivity: A resting-state functional magnetic resonance imaging pilot study. Journal of Neurotrauma 32 (17), pp. 1380 - 1384 (2015)

Polyakova, M.; Stuke, K.; Schümberg, K.; Mueller, K.; Schoenknecht, P.; Schroeter, M. L.: BDNF as a biomarker for successful treatment of mood disorders: A systematic & quantitative meta-analysis. Journal of Affective Disorders 174, pp. 432 - 440 (2015)

Polyakova, M.; Sonnabend, N.; Sander, C.; Mergl, R.; Schroeter, M. L.; Schroeder, J.; Schönknecht, P.: Prevalence of minor depression in elderly persons with and without mild cognitive impairment: A systematic review. Journal of Affective Disorders 152-154, pp. 28 - 38 (2014)

Holiga, Š.; Mueller, K.; Möller, H. E.; Sieger, T.; Schroeter, M. L.; Vymazal, J.; Růžička, E.; Jech, R.: Motor matters: Tackling heterogeneity of Parkinson’s disease in functional MRI studies. PLoS One 8 (2), e56133 (2013)

Mueller, K.; Sacher, J.; Arelin, K.; Holiga, Š.; Kratzsch, J.; Villringer, A.; Schroeter, M. L.: Overweight and obesity are associated with neuronal injury in the human cerebellum and hippocampus in young adults: A combined MRI, serum marker and gene expression study. Translational Psychiatry 2, e200 (2012)

Holiga, Š.; Möller, H. E.; Sieger, T.; Schroeter, M. L.; Jech, R.; Mueller, K.: Accounting for movement increases sensitivity in detecting brain activity in Parkinson's disease. PLoS One 7 (5), e36271 (2012)